Skip to Main Content

Paper Details

The tumor microbiome as a predictor of outcomes in patients with metastatic melanoma treated with immune checkpoint inhibitors.
bioRxiv
2
2023
Author NameAffiliation
Martin D McCarterUniversity of Colorado School of Medicine
  • 1 - 1

Datasets

Release 1.2